Analysis Astec LifeSciences Limited (ASTEC)
5/29/2024
Analysis of Astec LifeSciences Limited (ASTEC)
Astec LifeSciences Limited has been showing a downward trend in its stock price over the past few days. The Relative Strength Index (RSI) values have been hovering around 40-48, indicating a neutral to slightly bearish sentiment in the market.The Moving Average Convergence Divergence (MACD) indicator has been negative, with the MACD line consistently below the signal line. This suggests a bearish momentum in the stock.
The Moving Average (MA) indicator has been above the stock price, indicating a potential resistance level. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have all been above the stock price, further confirming a bearish sentiment.
Overall, based on the technical indicators, Astec LifeSciences Limited may continue to face downward pressure in the near term. Investors should closely monitor the RSI, MACD, and moving averages for any signs of a potential reversal in the trend.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating good financial performance. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows a solid return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the beta, moving averages, and the range of the stock price over the past year.
Valuation metrics reveal the company's price-to-earnings ratios, enterprise value, price-to-book ratio, price-to-sales ratio, and market capitalization.
Lastly, dividends and splits information includes details about dividend rates, payout ratios, dividend dates, and historical splits.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an average annual growth rate of 11%.
- However, in the past 5 years, the company has experienced a higher average annual growth rate of 20.1%.
Overall, the company is expected to maintain a solid growth trajectory, with a slightly lower growth rate in the short term compared to the long-term average.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions, with the low end at $164, the high end at $250, and the median at $200. The average forecast is slightly higher at $202.26. The current price of the security is $191.57, which is below both the average and median forecasted prices.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in sales from 2022 to 2023.
- Prior to the decrease, there was a consistent increase in sales from 2020 to 2022.
- Overall, there has been significant growth in revenue over the four-year period.
These trends in revenue can provide insights into the company's performance and market conditions over the specified fiscal years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been investing more in non-current assets over the years.
7. There is a fluctuating trend in current assets, possibly due to changes in short-term investments and receivables.
8. The company has been relying more on long-term debt to finance its operations.
9. Retained earnings have been positive throughout the years, indicating profitability and reinvestment in the business.
10. The company has been maintaining a healthy balance between assets, liabilities, and shareholders' equity.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
4. Investing activities include significant amounts related to the sale and purchase of investments, with fluctuations in capital expenditures.
5. The end cash position has varied over the years, reaching its highest value in 2020 and its lowest in 2022.
6. Interest paid and income tax paid have also shown variations, impacting the company's cash flow position.
7. Overall, the company's cash flow statement reflects a mix of operational, financing, and investing activities that have influenced its financial position over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a range from $1.27 to $1.36. This shows growth compared to the EPS of $1.26 from a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a range from $1.44 to $1.63. This indicates an increase compared to the EPS of $1.46 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a range from $6.43 to $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a range from $6.40 to $7.90. This forecast suggests an improvement compared to the EPS of $6.59 from the current fiscal year.
Overall, the analysts are predicting growth in earnings per share for both the upcoming quarters and the full fiscal years, indicating positive expectations for the company's performance.
MACD of ASTEC
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
